U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C42H57ClN4O5S
Molecular Weight 765.4464
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MURIZATOCLAX

SMILES

C[C@@]1([H])C/C(/[H])=C(\[H])/[C@](CN2CCN3CCCC[C@]3([H])C2)([C@]4([H])CC[C@@]4([H])CN5C[C@@]6(CCCc7cc(ccc76)Cl)COc8ccc(cc85)C(=NS(=O)(=O)[C@]1([H])C)O)OC

InChI

InChIKey=BJTFTQIBRVBSBH-VCQPVEJUSA-N
InChI=1S/C42H57ClN4O5S/c1-29-8-6-18-42(51-3,27-45-20-21-46-19-5-4-10-35(46)25-45)37-14-11-33(37)24-47-26-41(17-7-9-31-22-34(43)13-15-36(31)41)28-52-39-16-12-32(23-38(39)47)40(48)44-53(49,50)30(29)2/h6,12-13,15-16,18,22-23,29-30,33,35,37H,4-5,7-11,14,17,19-21,24-28H2,1-3H3,(H,44,48)/b18-6+/t29-,30+,33-,35+,37+,41-,42-/m0/s1

HIDE SMILES / InChI

Molecular Formula C42H57ClN4O5S
Molecular Weight 765.4464
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Jun 26 15:39:50 UTC 2021
Edited
by admin
on Sat Jun 26 15:39:50 UTC 2021
Record UNII
BO0V7196L2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MURIZATOCLAX
INN   USAN  
Official Name English
(13S,31R,32R,4R,5E,8S,9R)-6'-CHLORO-4-METHOXY-8,9-DIMETHYL-4-(((9AR)- OCTAHYDRO-2H-PYRIDO(1,2-A)PYRAZIN-2-YL)METHYL)-3',4'-DIHYDRO-12H,14H,2'HSPIRO( 10.LAMBDA.6-THIA-11-AZA-1(5,7)-(1,5)BENZOXAZEPINA-3(1,2)- CYCLOBUTANACYCLODODECAPHAN-5-ENE-13,1'-NAPHTHAL
Systematic Name English
SPIRO(5,7-ETHENO-1H,11H-CYCLOBUT(I)(1,4)OXAZEPINO(3,4-F)(1,2,7)THIADIAZACYCLOHEXADECINE-2(3H),1'(2'H)-NAPHTHALEN)-8(9H)-ONE, 6'-CHLORO-3',4',12,13,16,16A,17,18,18A,19-DECAHYDRO-16-METHOXY-11,12-DIMETHYL-16-(((9AR)-OCTAHYDRO-2H-PYRIDO(1,2-A)PYRAZIN-2-YL)M
Systematic Name English
MURIZATOCLAX [USAN]
Common Name English
MURIZATOCLAX [WHO-DD]
Common Name English
AMG-397
Code English
MURIZATOCLAX [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 675018
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
FDA ORPHAN DRUG 698019
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
FDA ORPHAN DRUG 674818
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
Code System Code Type Description
PUBCHEM
138669688
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
PRIMARY
NCI_THESAURUS
C156740
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
PRIMARY
CAS
2245848-05-7
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
PRIMARY
FDA UNII
BO0V7196L2
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
PRIMARY
INN
11281
Created by admin on Sat Jun 26 15:39:51 UTC 2021 , Edited by admin on Sat Jun 26 15:39:51 UTC 2021
PRIMARY
Related Record Type Details
TRANSPORTER -> INHIBITOR
IC50
TARGET -> INHIBITOR
In-vitro, AMG 397 neutralizes the interaction between the human anti-apoptotic MCL1 – (BIM) in a time-resolved fluorescence resonance energy transfer-based assay with a mean half-maximal inhibitory concentration (IC50) of 0.116 nM
IC50
TRANSPORTER -> SUBSTRATE
Efflux ratio of 100 at 1?M versus 4 with Pg-p inhibitor
Related Record Type Details
ACTIVE MOIETY